(Q35807249)

10 August 2017

1 reference

title

Immunosuppression for long-term maintenance of renal allograft function (English)

1 reference

10 August 2017

1 reference

Gerd Offermann

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

12

1 reference

10 August 2017

page(s)

1325-1338

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464120-00005

10 August 2017

exact match

0 references

cites work

Avoiding steroids in solid organ transplantation

1 reference

12 December 2020

Predicting long-term kidney graft survival: can new trials be performed?1,2

1 reference

12 December 2020

Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts

1 reference

12 December 2020

Pathogenesis of chronic allograft rejection

1 reference

12 December 2020

Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation

1 reference

12 December 2020

Control of risk factors for cardiovascular disease in long-term renal transplant recipients

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients

1 reference

12 December 2020

Chronic allograft nephropathy: An update

1 reference

12 December 2020

Mycophenolate mofetil and its mechanisms of action

1 reference

12 December 2020

A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients

1 reference

12 December 2020

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies

1 reference

12 December 2020

Strategies to improve long-term outcomes after renal transplantation

1 reference

12 December 2020

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

12 December 2020

Risk factors for late kidney allograft failure

1 reference

12 December 2020

Cyclosporin A withdrawal in live related renal transplantation: long-term results

1 reference

12 December 2020

Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study

1 reference

12 December 2020

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

12 December 2020

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group

1 reference

12 December 2020

One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation

1 reference

12 December 2020

Lack of long-term benefits of steroid withdrawal in renal transplant recipients

1 reference

12 December 2020

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

12 December 2020

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

12 December 2020

Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation

1 reference

12 December 2020

A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients

1 reference

12 December 2020

Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?

1 reference

12 December 2020

Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy

1 reference

12 December 2020

Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation

1 reference

12 December 2020

Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

1 reference

12 December 2020

Review and preview of anti-T-cell antibodies.

1 reference

12 December 2020

Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group

1 reference

12 December 2020

Twenty years of renal transplantation at Ohio State University: the results of five eras of immunosuppression

1 reference

12 December 2020

Relevant targets for therapy with monoclonal antibodies in allograft transplantation

1 reference

12 December 2020

Randomized study with cyclosporine in kidney transplantation: 10-year follow-up

1 reference

12 December 2020

Time dependency of factors affecting renal allograft survival

1 reference

12 December 2020

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

1 reference

12 December 2020

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group

1 reference

12 December 2020

The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol

1 reference

12 December 2020

Renal transplant recipient attitudes toward steroid use and steroid withdrawal

1 reference

12 December 2020

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus

1 reference

12 December 2020

Tacrolimus: a further update of its use in the management of organ transplantation

1 reference

12 December 2020

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

12 December 2020

Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration

1 reference

12 December 2020

Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome

1 reference

12 December 2020

Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial

1 reference

12 December 2020

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

1 reference

12 December 2020

The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy

1 reference

12 December 2020

Long-term survival in renal transplant recipients with graft function

1 reference

12 December 2020

Late conversion from steroids to azathioprine in cyclosporin-treated renal graft recipients

1 reference

12 December 2020

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

1 reference

12 December 2020

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group

1 reference

12 December 2020

Cyclosporine and long-term kidney graft survival

1 reference

12 December 2020

Renal function as a predictor of long-term graft survival in renal transplant patients

1 reference

12 December 2020

Mycophenolate mofetil in renal transplantation: five years experience

1 reference

12 December 2020

Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation

1 reference

12 December 2020

Predicting kidney graft failure using time-dependent renal function covariates

1 reference

12 December 2020

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients

1 reference

12 December 2020

Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function

1 reference

12 December 2020

Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.

1 reference

12 December 2020

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

1 reference

12 December 2020

Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune

1 reference

12 December 2020

Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis

1 reference

12 December 2020

Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study

1 reference

12 December 2020

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

12 December 2020

The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.

1 reference

12 December 2020

Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study

1 reference

12 December 2020

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation--4-year experience at a moderate-volume center

1 reference

12 December 2020

Vascular rejection with tacrolimus and potential long-term graft outcome

1 reference

12 December 2020

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

1 reference

12 December 2020

Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up

1 reference

12 December 2020

Calcineurin inhibitors in renal transplantation: what is the best option?

1 reference

12 December 2020

Impact of delayed graft function and acute rejection on graft survival

1 reference

12 December 2020

Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results

1 reference

12 December 2020

Sirolimus Delays Renal Allograft Recovery

1 reference

12 December 2020

Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.

1 reference

12 December 2020

Chronic immunosuppression of the renal transplant patient.

1 reference

12 December 2020

Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.

1 reference

12 December 2020

Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients.

1 reference

12 December 2020

Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury

1 reference

12 December 2020

Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil

1 reference

12 December 2020

Cyclosporine avoidance

1 reference

12 December 2020

Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy

1 reference

12 December 2020

Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy

1 reference

12 December 2020

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients

1 reference

12 December 2020

Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients

1 reference

12 December 2020

Chronic rejection with or without transplant vasculopathy

1 reference

12 December 2020

European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients

1 reference

12 December 2020

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

1 reference

12 December 2020

Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids.

1 reference

12 December 2020

Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus.

1 reference

12 December 2020

Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss

1 reference

12 December 2020

Cyclosporine (Sandimmun) in cadaveric renal transplantation. Ten-year follow-up of a multicenter trial. European Multicentre Trial Group

1 reference

12 December 2020

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

1 reference

12 December 2020

Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings

1 reference

12 December 2020

The mechanism of action of cyclosporin A and FK506

1 reference

12 December 2020

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

1 reference

12 December 2020

Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Long-term effects of steroid withdrawal in kidney transplantation.

1 reference

12 December 2020

A meta-analysis of immunosuppression withdrawal trials in renal transplantation

1 reference

12 December 2020

Annual trends and triple therapy--1991-2000.

1 reference

12 December 2020

Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.

1 reference

12 December 2020

Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study

1 reference

12 December 2020

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

1 reference

12 December 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

12 December 2020

Poor predictive value of serum creatinine for renal allograft loss

1 reference

12 December 2020

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins

1 reference

12 December 2020

10.2165/00003495-200464120-00005

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3em7kii7nhjnf2yn7sgk6tcbe

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1030342373

0 references

Fatcat ID

release_b3em7kii7nhjnf2yn7sgk6tcbe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3em7kii7nhjnf2yn7sgk6tcbe

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/b3em7kii7nhjnf2yn7sgk6tcbe

1 reference

30 July 2022